CervoMed Inc. — Director's Dealing 2016

Aug 30, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2016-08-11

Reporting Person: BLECH ISAAC (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	28334	Direct
Common Stock	11905	Indirect
Common Stock	154763	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$30.0000	2024-01-06	Common Stock (1745)		Direct
Stock Option (Right to Buy)	$39.2000	2024-07-23	Common Stock (8745)		Direct
Warrant (Right to Buy)	$380.0000	2017-08-20	Common Stock (5000)		Direct
Warrant (Right to Buy)	$48.0000	2018-10-21	Common Stock (7500)		Direct

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: Includes 11,905 shares owned by the River Charitable Remainder Unitrust f/b/o Isaac Blech, 71,429 shares owned by the West Charitable Remainder Trust and 71,429 shares owned by the Liberty Charitable Remainder Trust f/b/o Isaac Blech.

F3: The option was originally granted on January 7, 2014 and vested in full in accordance with the terms of the underlying option award agreement upon the completion of the Issuer's merger with Diffusion Pharmaceuticals LLC on January 8, 2016.

F4: The option was originally granted on July 24, 2014 and vested in full in accordance with the terms of the underlying option award agreement upon the completion of the Issuer's merger with Diffusion Pharmaceuticals LLC on January 8, 2016.

F5: Warrant is currently exercisable.